Urines of several patients with urothelial carcinomas contain inhibitors of the immunoreaction between carcinoembryonic antigen derived from human colorectal carcinomas and monospecific goat antiserum raised against the antigen. These inhibitors range in approximate molecular weights from less than 1000 to several millions, and two have been isolated by a combination of extraction, gel filtration and electrophoretic procedures. These are respectively a macromolecular aggregate, component UCEA-3, which is excluded by Sepharose 4B, and a glycoprotein(s) component, UCEA-1, with mean molecular weight (2x 105) similar to that of carcinoembryonic antigen. Comparison of the properties of component UCEA-1 and carcinoembryonic antigen on gel filtration, electrophoresis, immunoelectrophoresis and density gradient ultracentrifugation indicates that these substances of similar molecular size and net charge differ in some immunochemical properties.
described by Gold & Freedman (1965a,b) was originally thought to be a tumour-specific antigen found only in carcinomas and normal foetal tissues of endodermal origin. Improved assay techniques (Thomson et al., 1969; LoGerfo et al., 1971; Egan et al., 1972) showed that the concentration of the circulating antigen may decrease significantly after tumour resection and increase on tumour recurrence (LoGerfo etal., 1972; Laurence et al., 1972) . However, such materials may be found in the serum, faeces, urine and meconium of normal healthy subjects and in the serum of patients with a wide variety of non-neoplastic regenerative or inflammatory disorders and with non-endodermally derived benign and malignant neoplasms (Martin & Martin, 1970 ; Moore et al., 1971 Moore et al., , 1972 Freed & Taylor, 1972; Hall et al., 1972; Laurence et al., 1972; Reynoso et al., 1972; Kupchik & Zamcheck, 1973; Neville et al., 1973) .
The wide distribution of carcinoembryonic antigenic activity was ascertained primarily by radioimmunoassay, which measures only the degree of inhibition of the immunoreaction between carcinoembryonic antigen derived from colorectal carcinoma and its immunospecific antiserum. It is thus possible that some cross-reacting antigenic determinants are R. NERY, A. L. BARSOUM, H. BULLMAN AND A. M. NEVILLE
The electrophoresis apparatus (model U77) and analytical polyacrylamide-gel-electrophoresis apparatus were from Shandon Scientific Co. Ltd., London N.W.10, U.K., and ultrafiltration apparatus (model 2000) and membranes were from Amicon Ltd., High Wycombe, Bucks., U.K.
Aqueous buffer solutions
Phosphate-buffered saline solutions contained NaH2PO4 (50mmol), NaCl (150mmol) and NaN3 (3'.1 mmol) per litre of solution adjusted to pH5.8 or 7.2 with 1 M-NaOH. Phosphate-buffered saline-EDTA-rabbit immunoglobulin G (pH7.2) contained NaH2PO4 (22.5mmol), Na2HPO4 (52.5mmol), NaCl (75mmol), EDTA (0.8mmol) and rabbit immunoglobulin G (1 g) per litre of solution. Veronal buffer (pH8.6) contained sodium veronal (5Ommol) and veronal (lOmmol) per litre of solution. Borate buffer (pH8.6) contained Na2B407, JOH20 (25 .Smmol) and boric acid (75mmol) per litre of solution. Boratebuffered urea (pH8.6) contained urea (Smol) per litre of borate buffer.
Urines
These were obtained from patients with urothelial carcinoma at the Royal Marsden Hospital. The specimens were collected in sterile containers and stored at -20°C until required. Goat antiserum This, monospecific for carcinoembryonic antigen derived from colorectal carcinoma, was prepared from goats immunized with a standard purified preparation of the antigen as described by Darcy et al. (1973) .
Carcinoembryonic antigen
All preparations were from human colorectal carcinomas or their liver metastases. The standard preparation was a gift from Dr. C. W. Todd (City of Hope Medical Center, Duarte, Calif., U.S.A.), and was labelled with 1251 as described by Egan et al. (1972) 
Methods

Radioimmunoassay
This was performed by the double-antibody procedure of Egan et al. (1972) as modified by Laurence et al. (1972) . Briefly, inhibitor in phosphatebuffered saline-EDTA-rabbit immunoglobulin G (0.2ml) was mixed with suitably diluted monospecific goat anti-(carcinoembryonic antigen) antiserum (0.05ml) and a solution of '251-labelled standard antigen (1-2ng; 3xlO4c.p.m.) in the same buffer (0.01ml) containing kanamycin (26,g). The radioactivity of the mixture was determined with a gamma counter. The mixture was incubated overnight at 370C, mixed with undiluted horse anti-(goat immunoglobulin G) antiserum (O.1 ml), incubated for 1 h at 37°C, kept at 4°C for 15min and centrifuged. The supernatant was discarded and the radioactivity of the sediment determined as described above. The ratio of the radioactivities obtained before and after centrifugation gave the fraction of bound radioactivity; this, expressed as a fraction of the binding observed when a control solution containing buffer (0.2nl) in place of inhibitor was treated similarly, gave the percentage inhibition of binding. The antigenic activity of the inhibitor was calculated by reference to a standard curve in which known quantities of determined concentration-dependent activity of unlabelled standard antigen were added to incubation mixtures containing iodinated standard antigen and goat antiserum.
The carcinoembryonic antigen-like activity of urinary preparations is expressed as weight-equivalent antigenic activity, this being arbitrarily defined as that weight or concentration of the standard antigen required to give an equivalent inhibition in the radioimmunoassay. It is thus a measure to which the urinary sample competes with the standard antigen for the specific binding sites of the monospecific anti-(carcinoembryonic antigen) antibodies. This competition may be effected by shared structurally similar, or by structurally dissimilar, cross-reacting antigenic determinants.
Staining
Cellulose diacetate (Cellogel) (pg) and (iii) percentage (w/w) of antigenic activity of the product and (iv) percentage (w/w) recovery of antigenic activity in the purification step, in the order given. For comparison, the percentage (w/w) of antigenic activity of HC04 extracts of several human colorectal carcinomas and their metastases (Krupey et al., 1968; Coligan et al., 1972; Turberville et al., 1973) at corresponding stages of purification is also included. Antigenic activities were determined by the modified double-antibody radioimmunoassay procedure of Egan et al. (1972) . In this, incubation of the test substance and 125I-labelled carcinoembryonic antigen from colorectal carcinomas with goat monospecific anti-(carcinoembryonic antigen) antiserum is followed by precipitation of the immunoglobulin G antibodies and their immune complexes with horse anti-(goat immunoglobulin G) antiserum; the amount of bound radioactivity in the precipitate, by reference to suitable controls and standards, gives the antigenic activity of the sample. procedures of Bodman (1968) or Zacharius et al. (1969) , respectively.
Ultrafiltration
Urine samples were clarified by centrifugation at 2200g at 4°C for 30min and the supernatant solutions were filtered in the Amicon ultrafiltration apparatus with stirring at 4°C.
Gel-filtration chromatography
The packed columns were developed overnight or longer with phosphate-buffered saline (pH5. Cellogel blocks (6cmx I7cmx2.5mm) or strips (2.7cmx 14cm or 5.7cmx 11cm) were soaked overnight in buffer and blotted between sheets ofWhatman 3MM filter paper. The sample was evenly distributed on a Cellogel block with a Hamilton microlitre syringe, with its tip cut off and blunted, at a distance (2cm) from the cathodic end of the block along pinholes (0.4mm deep and 2mm apart). The ends of the block were connected to the buffer compartments of the electrophoresis apparatus with bridges of Whatman 3MM filter paper. Electrophoresis was performed at 20°C at 24mA for 2h or 4h in veronal or borate buffer, pH8.6. The block was cut into transverse sections 5mm wide, except for the first section, which extended from -0.5cm to +0.5cm towards the anode. Each section was placed in a numbered test tube, the absorbed liquid was squeezed out with a glass rod with a thickened end and the antigenic activity of the exudate was determined by radioimmunoassay. Fractions containing antigenic activity were combined. The Cellogel slices were loosely packed into a small chromatographic column (1cmx20cm) and eluted with water (about 30ml) until no further activity was eluted. The eluate was filtered through Whatman no. 42 filter paper and de-salted by passage through a small column (1 cm x 20cm) of Sephadex G-25. The Sephadex G-25 column was further eluted with water (5ml) and the effluents were combined and dialysed in Visking tubing against several changes of deionized doubledistilled water for 2 days at 4°C and freeze-dried. Protein and glycoprotein bands on electrophoretograms were located by pressing duplicate 1cm-wide strips of Whatman no. 1 filter paper along the length of the block followed by staining of the resulting 'prints' with Coomassie Brilliant Blue and the periodate-Schiff reagent respectively. For electrophoresis on Cellogel strips, the samples were applied as discrete spots approx. 4cm from the cathodic end of the strips with the blunt Hamilton microlitre syringe. The strips were connected to the buffer compartments with Whatman 3MM filter-paper bridges. For immunoelectrophoresis on Cellogel strips, the samples were applied similarly, 2cm apart; after electrophoresis, strips of Whatman no. 1 filter paper (2mm wide) evenly wetted with the undiluted antiserum (40100,ul) were placed lengthwise on the electrophoretogram at a distance (9mm) from the edge of the strip to the line of development of the sample. The Cellogel strip was placed over a hole cut slightly smaller than the dimensions of the strip through a wad of Whatman 3MM filter paper wetted with the electrophoresis buffer and placed in a moist chamber for 60-72h at room temperature. The immunoelectrophoretogram was washed by agitation in several changes of phosphate-buffered saline (pH7.2) during 8-16h and stained with Nigrosine. Unlike immunodiffusion in agarose (see below), precipitin lines on Cellogel were visible only after staining.
Disc electrophoresis on polyacrylamide gels
This was done by the method of Ornstein & Davis (Davis, 1964) . The sample (20-30,ug) was dissolved in the appropriate electrophoresis buffer (10-15,pl) containing, where appropriate, dissolved urea (50-754umol) and/or dithiothreitol (0.4-0.6pmol).
Immunodiffusion in agarose
This was done on glass microscope slides (7.6cm x 2.5cm) coated to a depth of 2mm with a 1.5% (w/v) solution of agarose in veronal buffer. Preliminary immunotitration experiments were performed to establish optimum dilutions of antigen and antiserum required for the formation of visible immunoprecipitates.
CsCl density-gradient centrifugation
This was done in an MSE Superspeed 65 centrifuge by using a 3 x 5ml aluminium swing-out rotor with a maximum relative centrifugal force of 178000g. Samples were dissolved in 0.1M-sodium phosphate buffer (pH7.4; 5ml) containing CsCl (2.9g) and centrifuged at 120000g at 4°C for 80h. The density at 250 (p25) of each fraction (16 drops) collected from the bottom of the centrifuge tube was calculated from the refractive index at 25°C (nD25) by using the relationship: p25 = 10.8601 nD25-13.4974 (Ifft et al., 1961 (lOOml) , obtained after centrifugation ofurine at 2200g for 30min, was ultrafiltered through the UM-2 filter. The eluate (fraction 1) was kept and the residue was dissolved in phosphate-buffered saline (pH7.2, 50ml) and ultrafiltered successively through XM-300, XM-1OOA and PM-30 filters. The residue on each filter (respectively fractions 2-5) was dissolved in the same buffer (lOOmil). (B) A HCl04-soluble fraction (HC104 extract) of the solution of the material retained by the XM-300 filter (i.e. of the fraction having an approx. mol.wt. over 3 x 105) was ultrafiltered successively through the last three filters as for (A) and each residue was dissolved in phosphate-buffered saline (pH7.2; 25ml). (C) The residue (3.5g wet wt.), obtained after centrifugation of the same urine (10 litres), was suspended in glycine-HCl buffer (0.1 M, pH2.0, 35ml) and incubated at 37°C for 30min. The incubation mixture was centrifuged at 25000g at 4°C for 1 h and the supernatant (glycine buffer extract) was dialysed against water, ultrafiltered successively through the last three filters as above, and each residue was dissolved in phosphate-buffered saline (pH7.2; 25ml). (D) An aqueous solution (20ml) of carcinoembryonic antigen (lOg) purified from colorectal carcinoma on Sephadex G-200 (CEA solution) was ultrafiltered successively through XM-300, XM-1OOA, PM-30 and UM-2 filters and each residue was dissolved in phosphatebuffered saline (pH7.2, 50ml). The antigenic activity of the various subfractions was determined by radioimmunoassay. (Fig. 1) . Radio- immunoassay of effluent fractions from VI/Vo 0.8 to 3.6 showed two main antigenically active peaks; Ve/ Vo Fig. 1 . Sepharose 4B chromatography ofa HCIO4-solublefraction ofurinefrom a patient with bladder carcinoma
The urine (24 litres) was concentrated under reduced pressure at 4°C and a HCl04-soluble fraction of the concentrate was prepared. A sample (3.6g) of the dialysed and freeze-dried acid-soluble fraction (4.85g) was fractionated on a column (10cm x 80cm) of Sepharose 4B by elution with phosphate-buffered saline (pH 5.8; 0.05 M). The antigenic activity (o), arbitrarily defined as that weight or concentration of a standard preparation of carcinoembryonic antigen derived from colorectal carcinoma required to give an equivalent activity in the radioimmunoassay, and the E280 ( ) of effluent fractions (25 ml) were determined. The elution (0) of antigenic activity from a sample (5 mg) of carcinoembryonic antigen from colorectal carcinoma is also shown.
one, designated component UCEA-3, appeared in the void volume and the other, designated component UCEA-1, at V,1VO 2.40. Carcinoembryonic antigen derived from colorectal carcinoma was eluted from the same column, under the conditions described, at VeIVo 2.36. Freeze-dried products (1.75g and 0.126g) were obtained from the peaks containing components UCEA-1 (V,/Vo 2.2-2.6) and UCEA-3 (V,/VO 0.9-1.2) respectively. Radioimmunoassay indicated that these contained 0.5% (w/w) and 0.3% (w/w) of the activity of the standard carcinoembryonic antigen, representing 60% and 2.6% respectively of the total activity placed on the column (Scheme 1).
In another experiment, the urine concentrate was dialysed in Visking tubing against several changes of water at 4°C for 3 days. The non-diffusible fraction was freeze-dried and the residue (3.2g) fractionated through the same Sepharose 4B column under the conditions described above. Radioimmunoassay of effluent fractions showed two main peaks of antigenic activity centred at VeIV0 1.1 and VeIVo 2.4. The effluents within the V,/Vo range 0.9-4.2 were combined into four fractions with cut-off points at the following VeIVo values: 1.2, 2.3, 2.7. Radioimmunoassay showed that the resulting four fractions contained approx. 8, 17, 60 and 15 % of the total antigenic activity eluted from the column.
Gelfiltration on Sephadex G-200. The freeze-dried product (1.75g) containing fraction UCEA-1 obtained from Sepharose 4B chromatography (Fig. 1) was dissolved in phosphate-buffered saline (pH5.8; 10ml) and chromatographed on a column (7.5cmx84cm) of Sephadex G-200. A broad peak of antigenic activity, extending from Ve!_VO 1.0 to 1.6, was obtained; this gave a freeze-dried product (324mg) having an antigenic activity of 2.2 % (w/w). Rechromatography of a sample (198mg) of this product, as described above, gave a major peak of antigenic activity (Scheme 1) centred at V,/V0 1.20. The combined fractions (V,/ Vo 1.1-1.25) gave a freeze-dried product (165mg) with an antigenic activity of 2.5% (w/w). Unless otherwise stated, further experiments with fraction UCEA-1 refer to this preparation. A solution of carcinoembryonic antigen (2mg) derived from colorectal carcinoma in phosphate-buffered saline (pH5.8; SmI), after 1974 436 CARCINOEMBRYONIC ANTIGEN similar chromatography, showed a peak of antigenic activity centred at VJ/Vo 1.18.
Cellogel block electrophoresis. Fraction UCEA-1 (7.5mg) in borate buffer (pH8.6; 0.4ml) was subjected to electrophoresis on Cellogel blocks at 24mA for 35min. A similar sample was electrophoresed for 2h in the same buffer. Fraction UCEA-1 (7.5mg) in veronal buffer (pH8.6; 0.4ml) was similarly treated for 4h in veronal buffer. The results showed a major glycoprotein band coincident with the peak of antigenic activity at 0.5-2.0, 2.0-3.5 and -0.5-2.0cm from the origin towards the anode for the three samples in the order given. These gave freeze-dried products (4.2mg, 2.9mg and 5.0mg) with 2.8, 3.0 and 2.5 % (w/w) respectively of the antigenic activity of the standard carcinoembryonic antigen.
Immunodiffusion in agarose
Fraction UCEA-1 (150#ug) obtained from Sephadex G-200 chromatography of urine from a female patient with bladder carcinoma, or carcinoembryonic antigen (15,g) derived from colorectal carcinoma in veronal buffer, pH8.6 (10,ul), after immunodiffusion in a moist chamber at room temperature for 60h against monospecific goat anti-(carcinoembryonic antigen) antiserum (30,ul, undiluted) showed precipitin lines of antigenic identity. However, variations in this antigenic property of carcinoembryonic antigen-like substances in the urines of individual patients with bladder carcinoma may occur; in one case, lines of partial antigenic identity were seen (Dr. D. Darcy, personal communication) and, in at least three others, precipitin lines of apparent antigenic identity were produced with difficulty. The lower limit of detection of the antigen(s) by this method is at least 1000 times greater than that achieved by radioimmunoassay. This low sensitivity, which is further decreased by the low (i.e. 3%) specific (w/w) antigenic activity of the urinary preparations, may account for the difficulty. 
Electrophoresis in polyacrylamide gels
Preliminary experiments with fraction UCEA-1 and using separation gels of 5, 7.5, 10, 15, 25 and 30% (w/v) subjected to electrophoresis in this buffer in 15% (w/v) gels at 3mA/gel for 7h and the gels were stained by using the periodate-Schiff procedure of Zacharius et al. (1969) . Apparently identical bands (Fig. 2) were revealed for both substances with electrophoretic mobilities of 0.67mm/h per mA.
Heterogeneity of fraction UCEA-1 and of carcinoembryonic antigen derived from colorectal carcinoma Centrifugation on a CsCl density gradient of a sample of component UCEA-1 (50,ug) or of carcinoembryonic antigen (5pg) showed three peaks of antigenic activity at densities of 1.58, 1.54 and 1.48 for component UCEA-1 and 1.58, 1.53 and 1.48 for the other antigen in increasing order of relative proportions. A sample (2,ug) of carcinoembryonic antigen obtained from the apex of a DEAE-cellulose chromatographic peak , and a sample (20gg) of fraction UCEA-1, further purified by electrophoresis on a Cellogel block in borate buffer for 2h, showed a relative loss of the less dense components of both substances (Fig. 3) .
Discussion
Human colorectal adenocarcinomas or their metastases are known to contain at least three glycoproteins giving positive values in radioimmunoassay for the carcinoembryonic antigen derived from colorectal carcinomas. These include that described initially by Gold & Freedman (1965a,b) , a second of lower molecular weight (Mach & Pusztaszeri, 1972; Kleist etal., 1972; Darcy et al., 1973; Turberville et al., 1973 ) and a third, isolated from a liver metastasis of a human colonic carcinoma of larger molecular size . The second glycoprotein also occurs in other tumours and in the urines of patients with urothelial carcinomas . The present report indicates that such urines also contain, among others, a carcinoembryonic antigen-like glycoprotein of size similar to that of the first antigen and a macromolecular aggregate which appears to be different from the third.
The urines of patients with urothelial carcinoma may contain abnormally increased amounts of substances giving positive values in radioimmunoassay for the carcinoembryonic antigen derived fro&n colorectal carcinoma; these amounts may be further increased if urinary infection or contamination of the urines with vaginal or cervical secretions from these patients is present (Hall et al., 1972) . The present results show that the urinary materials measured by radioimmunoassay (Hall et al., 1972) consist of several species ranging in apparent molecular weights from less than 103 to over 2x 107. Moreover, fractionation of infected and non-infected urines from some 40 patients with urothelial carcinoma by gel 1974 440 R. NERY, A. L. BARSOUM, H. BULLMAN AND A. M. NEVILLE relationship of these substances to one another clearly requires more detailed studies of the purified components.
